South Africa's Aspen sells Australian prescription portfolio to Mylan

Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news